Centene (CNC) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$202.9B

Revenue (quarter)

$53.6B

Revenue growth (year over year)

+9.92%

Gross profit (trailing twelve months)

$40.5B

Gross margin

19.93%

Net income (trailing twelve months)

−$5.1B

Net income (quarter)

$1.1B

Net income growth (year over year)

+519.69%

Net margin

−2.52%

Return on equity

−20.40%

EPS (trailing twelve months)

−$10.33

Book value per share

$45.72

P/E (trailing twelve months)

—

Price to book

1.53

Debt to assets

72.71%

Payout ratio

—

Dividend yield

—

Company profile

Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.

• Is Centene (CNC) profitable?

  No. Centene reported a net loss of $5.1B over the trailing twelve months.

• How much revenue does Centene (CNC) make?

  Centene generated $202.9B in revenue over the trailing twelve months, up 9.92% year over year.

• How do I buy stock in Centene (CNC)?

  CNC trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.